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ABSTRACT
Objective: Formulation of Singawalang leaves extract should be considered because the extract contains a variety of compounds so that there may 
be a competitor in the absorption process and will cause the absorption of active ingredients in the gastrointestinal decline. One way to increase the 
absorption and disposition of active ingredients on target organs is to use a nanoparticle formulation. Therefore, this study will conduct research on 
self-nanoemulsifying drug delivery system (SNEDDS) formulation of Singawalang (Petiveria alliacea) leaves extract.
Methods: The systems were developed by investigating the solubility Singawalang leaves extract in various carrier oil, the suitable surfactant, 
and cosurfactant, construction of SNEDDS of Singawalang leaves extract and characterization of droplet size through particle size analyzer and 
transmission electron microscopy.
Results: The results of this study indicate that the optimum carrier oils for Singawalang leave extract are miglitol and virgin coconut oil (VCO), 
the compatible surfactant component is tween 80 and the compatible cosurfactant is propylene glycol (PG). The average droplet size is 13 nm and 
polydisperse index 0,004 and 0,006.
Conclusion: It can be concluded, the present study demonstrated that the optimum SNEDDS formulations of Singawalang leave extract are the 
mixture of VCO, tween 80, PG at ratio 1:8:1 and miglitol, tween 80, and PG at ratio 2:5:3.
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INTRODUCTION
Singawalang (Petiveria alliacea) is a plant widely found in Indonesia 
and empirically used by residents to treat various diseases such as 
diabetes and bleeding cough and is also used to protect plants from 
pests. The ethanol extract of Singawalang leaves has the ability to 
lower blood sugar levels [1,2]. Mustika et al., 2015, also showed that 
extract of Singawalang leaves decreased blood sugar level in the mouse 
model of type 2 diabetes mellitus (T2DM) with the optimum dosage 
of 360 mg/kg BW and also increased 5’ adenosine monophosphate-
activated protein kinase expression on liver [3]. This phenomenon 
raises the hope that the extract can be used as a phytopharmaca drug in 
the management of T2DM.
The extract of Singawalang leaves contains a complex of active 
compounds so that there may be a competition between several active 
compounds in the absorption process and will cause the absorption 
of active compounds in the gastrointestinal decline. Herbal medicine 
also has some problems such as instability and solubility formulation, 
low absorption because unable to cross the lipid membranes of the 
cells, larger molecular size, numerous large of chemical molecules, 
degradation during gastric emptying, and extensive metabolism [4,5]. 
Therefore, the formulation of drug dosage forms and active material 
delivery systems plays an important role in determining their 
therapeutic effects. Therefore, it is necessary to do good research on 
the formulation of the dosage form of leaves extract Singawalang.
The nanomaterials can expressively enrich the pharmacokinetics, 
pharmacodynamic, and therapeutic index of phytomedicines. In 
accordance with micrometer-sized, nanocarriers are responsible for 
more surface area and increase solubility, bioavailability, and enable 
appropriate nanomedical targeting [4,6,7]. The advantages for herbal 
medicines nanoparticles formulation are including increased solubility 
and bioavailability, protection from toxicity, increased pharmacological 
activity, increased stability, improved tissue distribution, continuous 
shipping, and physical protection and chemical degradation [8,9]. 
Various research has been developed to improve the formulation and 
delivery system that aims to increase the levels of active ingredients to 
target organs, one of which is by the delivery of active ingredients in the 
nanoparticle system [10,11].
The system of lipid-based drugs has achieved increased interest in the 
oral route of administration of poorly bioavailable drugs. This lipid 
system is absorbed by lymphatic system through Peyer patch along 
the gastrointestinal tract. The self-nanoemulsifying drug delivery 
system (SNEDDS) is one of the systems for the delivery of lipid-based 
drugs that have now been investigated for its benefit, providing a large 
interfacial area to partition the drug between oil and gastrointestinal 
fluids. This technique increases the oral bioavailability of drugs that 
are difficult to dissolve by increasing solubility and keeping the drug 
dissolved, in small droplets of oil, throughout its transit through the 
digestive tract. The SNEDDS has recently emerged as an approach to 
improve oral solubility, dissolution, and absorption for poorly water-
insoluble drugs [12,13].
SNEDDS is a type of self-emulsifying drug delivery system that contains 
an isotropic mixture of oil, surfactants, cosurfactants, and medicinal 
substances, which can form nanoemulsion in the digestive tract after 
oral administration. Emulsions produced with particle sizes <100 nm 
increase the solubility of hydrophobic drugs and increase their 
absorption. SNEDDS is an isotropic mixture of oil, surfactants, and 
cosurfactants that form oil-in nanoemulsions in fine water, in mild 
agitation, followed by administration into aqueous media, such as 
gastrointestinal fluids [14].
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Thus, considering its potential benefits, we have developed a 
novel SNEDDS of Singawalang leaves extract and evaluated its 
characterization. The aim of this study was to make a formulation of 
Singawalang leaves extract in a SNEDDS and their characterization. The 
SNEDDS were developed by investigating the solubility of Singawalang 
leaves extract in various carrier oil, the suitable surfactant, and 
cosurfactant, construction of SNEDDS of Singawalang leaves extract, 
and self-emulsification time and percentage transmittance in artificial 
gastric fluid (AGF). Furthermore, the droplet size characterization of 
Singawalang leaves extract was evaluated through particle size analyzer 
and transmission electron microscopy (TEM).
MATERIALS AND METHODS
Materials
P. alliacea leaves were collected from Balai Materia Medika (BMM) 
Batu, East Java, Indonesia and were determined by BMM. Ethanol 96%, 
virgin coconut oil (VCO), sunflower, olive oil, sesame oil, fish oil, soya 
oil, canola oil, rice oil, corn oil, span 20, span 80, tween 20, and tween 
80 were used. PEG 400, propylene glycol (PG) was purchased from 
Brataco, miglitol from the Department of Biopharmaceutics, Faculty of 
Pharmacy of Universitas Gadjah Mada, Yogyakarta.
Methods
Formulation of SNEDDS of Singawalang leaves extract
Extraction of Singawalang leaves
1000 g of Singawalang leaves powder has been extracted with 70% 
ethanol solvent. The extraction was done by maceration for 3 days.
Selection of SNEDDS components
Solubility test of carrier oil
Testing solubility of Singawalang leaves extracts in various oil. The oil 
used is VCO, sesame oil, olive oil, corn oil, sunflower oil, fish oil, soya oil, 
and migltiol. 50 mg of ethanol extract of Singawalang leaves is put into 
5 mL each oil gradually until saturated. The mixtures were vortexed as 
long as 5 min and sonicated during 3 times–15 min. Solubility will be 
visually observed.
Emulsification studies of surfactant
A surfactant was selected on the ease of emulsification and solubility 
by visual. Various surfactants (span 20, span 80, tween 20, and tween 
80) were selected to determine the emulsification ability of the selected 
oil phase. Mixture the amount of selected oil and the amount of each 
surfactant in the tube with ratio 1:1, mix it by gently shaking the tube 
to determine the ease of emulsion. The amount of shake is used to 
determine the ease of emulsion. Allow the emulsion for 2 h, and the 
optical clarity of aqueous dispersion was visually observed.
Emulsification studies of cosurfactant
Cosurfactant was selected on the ease of emulsification and solubility 
by visual. Various cosurfactants such as PEG 200, PEG 400, and PG 
were tested to find an appropriate formulation. Mixture the amount of 
surfactant and the amount of cosurfactant in the tube with ratio 2:1, 
mix it by gently shaking the tube to determine the ease of emulsion. 
The amount of shake is used to determine the ease of emulsion. Allow 
the emulsion for 2 h, and the optical clarity of aqueous dispersion was 
visually observed.
Construction of SNEDDS
The series of SNEDDS was formulated with varying concentrations 
of oil (25–70% w/w), surfactant (30–75% w/w), and cosurfactant 
(0–25% w/w) (Table 1) at room temperature (25°C) for 72 h. For any 
mixture, the total of surfactant, cosurfactant, and oil concentration 
added was always 100%. Each formulation was homogenated with a 
stirrer as long as 30 min. The suitable systems were selected based on 
visually observed and percentage transmittance by ultraviolet (UV)-VIS 
spectrophotometer at ƛ 650 nm.
Formulation of SNEDDS of Singawalang leaves extract was prepared 
based on the optimum suitable composition of oil, surfactant, and 
cosurfactant.
Loading drug
The series of the number of ethanol extracts of Singawalang leaves 
(50 mg, 75 mg, 125 mg, and 200 mg) was dissolved in 5 mL each Sneeds 
system. The formulation was homogenated by vortex 4 min, sonicator 
5 min, and heating in the water bath at 37°C as long as 15 min. The cycle 
was repeated 3 times. The evaluation of formulations was performed 
using self-emulsification time and percentage transmittance by UV-VIS 
spectrophotometer at ƛ 650 nm.
Self-emulsification time and percentage transmittance of Sneed 
formulation
In aquadestilata and AGF
The emulsification time was evaluated by 1000 μL of formulations 
incorporated into the 100 mL aquadestilata and into the 100 mL 
AGF with temperature 37°C and at centrifuge at a rate of 148 RPM. 
Time from starting formula was inserted until dissolved all called 
emulsification time. A sample was evaluated percentage transmittance 
of UV-VIS spectrophotometer at ƛ 650 nm.
AGF solution was prepared by mixing 1 g NaCl, 35 mL HCl 37%, and add 
aqueous until 500 mL. Adjust the pH until 1, 2 by adding NaOH. Adjust 
AGF solution temperature at 37°C.
Characterizations of SNEDDS of Singawalang leaves extract
Particle size analysis
Particle size and polydispersity index were obtained using particle 
size analyzer (HORIBA SZ-100). The polydispersity index reflects 
the uniformity of particle diameter and it can be used to depict the 
size distribution of nanoemulsion [15,16]. The sensitivity range was 
3–8000 nm. The measurements were performed at 25°C at a fixed angle 
of 90°.
TEM analysis
The extract Singawalang leaves SNEDDS droplet was observed by a 
transmission electron microscope. A sample was visualized by drying 
it on a carbon-coated grid and stained negatively with an aqueous 
solution of phosphotungstic acid 2%. After drying the phosphotungstic 
acid, the sample was observed under TEM [17]. Samples were analyzed 
at a lower accelerating voltage of 100 kV with a smaller objective 
aperture to achieve the contrast. Images were captured at ×40,000 
magnification.
RESULTS AND DISCUSSION
Formulation of SNEDDS of Singawalang leaves extract
Selection of SNEDDS components
The result showed that Singawalang leaves extract dissolved on VCO, 
miglitol, and corn oil (Table 1). Hence, these three oils can be used as 
oil components to make the nanoemulsion formulations. The result of 
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the test can be concluded that the compatible surfactant used to form 
the nanoemulsion formulation was tween 80, and cosurfactant was PG 
(Table 2).
SNEDDS formulation
The compatibility of oils, surfactants, and cosurfactants to acquire a 
higher transmittance was an essential foundation in the formulation of 
the nanoemulsion.
We choose ten compositions of SNEDDS formulation based on visual 
examination of oil, surfactant, and co-surfactant. The result of a visual 
examination, time of emulsification, and percentage transmittance are 
shown in Table 3.
In accordance with the results of visual observations, the emulsification 
time and percentage transmission, the formulas A, B, C, D, E, and F are 
chosen as the SNEDDS formulation.
Loading drug
The six SNEDDS formulations have been added the extract Singawalang 
leaves at dose 1 is 50 mg, dose 2 is 75 mg, dose 3 is 125 mg, and dose 
4 is 200 mg. The result of visual observation, emulsification time, and 
percentage transmittance in the AGF are shown in Table 4.
Characterizations of SNEDDS of extract Singawalang leaves
The mean of droplet size and the polydispersity index of SNEDDS 
extract Singawalang leaves are shown in Table 5.
The morphology of optimum SNEDDS and formulation of Singawalang 
leaves extract by TEM are shown in Fig. 1.
In this study, VCO, corn oil, and miglitol have been chosen as the carrier 
oil because the extract can dissolve well into the oil. VCO has a shorter 
chain of C atoms when compared with corn oil, thereby increasing the 
solubility of extract. The results of this study are also in accordance with 
the research conducted by Tri, 2018, that the solubility of Amomum 
compactum in VCO is better than in corn oil [18].
The solubility and emulsification studies were carried out to identify 
the suitable carrier oil, surfactant, and cosurfactant for the formulation 
of SNEDDS of Singawalang leaves extract. The result inferred that 
miglitol and VCO were found to solubilize of Singawalang leaves extract, 
tween 80, and span 80 as surfactant, and PG as cosurfactant. Tween 80 
as a non-ionic surfactant was found to have good solubility and better 
emulsification ability that allowed to rapid dispersion when in contact 
with a biological fluid. PG is a compatible cosurfactant that it can be 
used to enhanced solubility and bioavailability [18].
The data in the study show that all the test compositions of carrier 
oil, surfactants, can be used as SNEDDS formulations. Based on the 
Table 2: The surfactant and cosurfactant emulsification study
Surfactant Oil Cosurfactant
Corn Miglitol VCO PEG200 PEG400 PG
Span 20 Turbid Turbid Clear homogeneous Clear homogeneous Turbid
Span 80 Turbid Clear homogenous Clear homogenous Turbid Turbid Turbid
Tween 20 Turbid Turbid Turbid Turbid Turbid
Tween 80 Clear homogeneous Clear homogeneous Clear homogeneous Turbid Clear homogenous Clear homogenous
VCO: Virgin coconut oil, PG: Propylene glycol
Table 3: The effect of carrier oil, surfactant, and cosurfactant ratio on visual examination, time of emulsification, and percentage 
transmittance
Oil Ratio Result Code
Oil Surfactant (tween 80) Cosurfactant (PG) Visual Emulsifacation time (s) Transmittance (%)
Corn 1 1 1 Non-Homogeneous X X
1 7 2 Turbid X X
2 5 3 Turbid X X
2 6 2 Turbid X X
1 8 1 Turbid X X
VCO 1 1 1 Turbid X X
1 7 2 Clear 14 95,5 A
2 5 3 Turbid X X
2 6 2 Turbid X X
1 8 1 Clear 23 95,5 B
Miglitol 1 1 1 Turbid X X
1 7 2 Clear 25 95,4 C
2 5 3 Clear 21 95,5 D
2 6 2 Clear 15 95,2 E
1 8 1 Clear 25 95,4 F
VCO: Virgin coconut oil, PG: Propylene glycol
Fig. 1: The transmission electron microscopy image of droplet 
size of the Singawalang leaves extract self-nano emulsifying drug 
delivery system (SNEDDS) formula D4. The dark spherical shapes 
are indicated nanoparticle of SNEDDS contains Singawalang 
leaves extract. Magnification ×40,000
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emulsification time and the percentage of transmittance parameters, 
the composition with fast emulsification time is <15 s and percentage 
transmittance more than 95% is formula A (VCO: Tween 80:PG=1:7:2) 
and E (Migltiol: Tween 80:PG=1:8:1).
Emulsification time is known as important parameters to describe 
system stability and prepare emulsification in the gastric fluid 
characteristic of SNEDDS. The purpose of measuring percent 
transmittance is to observe the self-emulsification process by 
measuring the transmittance of the solution during dissolution when 
the emulsification process takes place.
Singawalang leaves extract up to a dose of 200 mg/5 mL can be 
entrapped in globules. It can be seen that in the visual observation, the 
formula remains clear and there is no sediment. The selected SNEDDS 
formulation was stable for 6 months at room temperature. Another 
study stated that SNEDDS of Plantago lanceolata was stable for 1 month 
at room temperature [19].
The range of particle size of all selected formulations is between 13 
nm and 18,7 nm. The size meets the nano criteria and approaches the 
DNA size of about 10 nm [20]. The range of particle sizes in the study of 
SNEDDS formulations containing P. lanceolata was between 141,51 and 
374,89 [19], while in the study of SNEDDS A, compactum, particle size was 
13,97 [18]. The average droplet size of tetrandine SNEDDS was 19.75 nm. 
The composition of SNEDDS formulation in this research consists of 40% 
(w/w) oleic acid as oil, 15% (w/w) SPC, and 30% (w/w) cremophor RH-
40 as surfactant, and 15% (w/w) PEG400 as cosurfactant [21].
Droplet size is an important factor in SNEDDS formulation because 
it determines the level and rate of drug release and absorption and 
increases in bioavailability as well there in vivo stability smaller 
droplets have a larger surface area, which then increases the level of 
drug release. The small droplet size may be due to increased surfactant 
concentration, which forms a closed layer of surfactant at the interface, 
so as to stabilize dispersed droplets [22]. Therefore, in this study, the 
nanosize of SNEDDS Singawalang leaves extract might allow it to be 
more easily delivered into cells or to pass across some barriers.
The carrier oil positively affects the formation of droplet size, and 
surfactant causes the interfacial film to stabilize and condense.
The polydispersity index of the B formulation (VCO: Tween 80:PG=1:8:1) 
was 0,006 and in the D formulation (Miglitol: Tween 80:PG=2:5:3) was 
0,004. This data show that the system had a narrow size distribution 
and homogeneity. Polydispersity index is the measure of globule 
size homogeneity. A value closer to zero, more homogeneous are the 
particles. The research of Embelin SNEDDS formulation showed that 
the polydispersity index was found to be 0,15±0,02–0,23±0,04 [23]. 
The mean droplet size and polydispersity index in myricetin SNEDDS 
were <200 nm with narrow distribution (<0,4) [15].
The electron microscope images in this study showed a spherical 
nanoemulsion droplet, measuring <100 nm. A similar morphology of 
droplet image has been shown in several previous studies such as SNEDDS 
curcumin and myricetin [15,24]. Spherical, discrete, and nonaggregate 
clots in the SNEDDS formulation deduce system stability [25].
Future prospects of SNEDDS Singawalang leave extract to have the 
potential to increase biological activity and overcome the shortcomings 
of herbal medicines. The latest new challenges in the development of 
nanotechnology-based drug delivery systems include the feasibility 
of scale-up process that brings innovative therapeutic techniques to 
market quickly and the possibility of obtaining a multifunctional system 
to meet several biological and therapeutic requirements.
At present, health-care costs must also be considered. This reduction in 
health-care costs is likely to be obtained by increasing nanotherapeutic 
efficacy, reducing its length hospitalization, reducing personal health-
care costs, and effective treatment of major expensive diseases [26].
Table 4: The result of visual observation, emulsification time, and percentage transmittance of self-nanoemulsifying drug delivery 
system Singawalang leaves extract formulation in artificial gastric fluid
Formulation Extract (mg) Visual Sediment Emulsification time (s) Percentage transmittance λ=650nm
A1 50 Clear None 1:23:6 60,2
A2 75 Clear None 2:02:3 69,2
A3 125 Clear None 1:44:6 58,6
A4 200 Clear None 1:45:1 55,4
B1 50 Clear None 0:59:1 78,7
B2 75 Clear None 0:49:4 70,5
B3 125 Clear None 0:46:4 61,4
B4 200 Clear None 0:35:8 32,9
C1 50 Clear None 0:38:1 79,5
C2 75 Clear None 0:32:2 72,6
C3 125 Clear None 0:51:3 56,0
C4 200 Clear None 0:41:2 39,4
D1 50 Clear None 0:20:5 75,5
D2 75 Clear None 0:25:1 74,5
D3 125 Clear None 0:20:2 55,5
D4 200 Clear None 0:30:2 43,8
E1 50 Clear None 0:26:5 80,3
E2 75 Clear None 0:32:9 74,0
E3 125 Clear None 0:39:1 59,5
E4 200 Clear None 0:38:1 54,6
F1 50 Clear None 0:23:8 79,6
F2 75 Clear None 0:30:9 86,1
F3 125 Clear None 0:38:8 52,1
F4 200 Clear None 0:37:2 34,2
Table 5: The mean of droplet size and the polydispersity 
index of self-nanoemulsifying drug delivery system extract 
Singawalang leaves
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Subsequent studies must be conducted to determine the factors that 
lead to increased delivery efficiency and bioavailability.
CONCLUSION
In the present study, SNEDDS of extract Singawalang leaves was 
successfully developed. The optimum composition of this system was 
VCO: Tween 80:PG with a ratio at 1:8:1 and miglitol: Tween 80:PG with 
a ratio at 2:5:3.
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